Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human beta-1,4-Galactosyltransferase 1/B4GalT1 Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 3 publications
Supplier: R&D Systems AF3609
This item is not returnable.
View return policy
Description
beta-1,4-Galactosyltransferase 1/B4GalT1 Polyclonal specifically detects beta-1,4-Galactosyltransferase 1/B4GalT1 in Human samples. It is validated for Western Blot, Immunoprecipitation.Specifications
beta-1,4-Galactosyltransferase 1/B4GalT1 | |
Polyclonal | |
Unconjugated | |
P15291 | |
B4GALT1 | |
Mouse myeloma cell line NS0-derived recombinant human beta-1,4-Galactosyltransferase 1/B4GalT1 long isoform Gly44-Ser398 Accession # P15291 | |
100 μg | |
Primary | |
Detects human beta-1,4-Galactosyltransferase 1/B4GalT1 in direct ELISAs and Western blots. | |
Human | |
IgG |
Western Blot, Immunoprecipitation | |
LYOPH | |
Western Blot 0.1 ug/mL, Immunoprecipitation 25 ug/mL | |
1,4- galactosyltransferase, polypeptide 1, B4GAL-T1, beta-1,4-galactosyltransferase 1, Beta-1,4-GalTase 1, Beta4Gal-T1, betaGlcNAc beta, CDG2D, EC 2.4.1, GGTB2, GGTB2DKFZp686N19253, glycoprotein-4-beta-galactosyltransferase 2, GT1, GTB, lactose synthase, MGC50983, UDP-Gal, UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1, UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1 | |
Goat | |
Affinity Purified | |
RUO | |
2683 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction